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The present study aimed to investigate the beneficial effects of the treatment with
extracts from the edible mushroom Lactarius deterrimus (Ld) and the chestnut Castanea
sativa (Cs), separately and in combination (MIX Ld/Cs), on oxidative stress and
advanced glycation end-product (AGE)-mediated hepatorenal injury in a rat model
of streptozotocin (STZ)-induced diabetes by examining pathways responsible for
maintenance of redox homeostasis. An experimental model of diabetes was induced
in rats by the administration of 40 mg/kg STZ intraperitoneally (i.p.) for 5 consecutive
days. The examined extracts were applied separately at a dose of 60 mg/kg i.p. and in
combination (60 mg/kg each extract; i.p.) for 4 weeks, starting from the last day of STZ
administration. The improvement of hepatorenal function in diabetic rats treated with the
extracts was associated with an improved glycemic and lipid status and suppression
of oxidative stress and thereby oxidative damage of lipids and DNA. Besides the fact
that both extracts inhibited protein glycation and AGE formation in vitro, they also
reduced non-enzymatic glycosylation in diabetic rats in vivo. The observed antiglycation
activity of the examined extracts (separately and in combination) was accompanied
with the inhibition of CML-mediated RAGE/NF-κB activation and reduction of enzymatic
O-GlcNAcylation in liver and kidney tissues of diabetic rats. Taken together, these results
reveal that the administration of chestnut and mushroom extracts, either individually
or together, activates a coordinated cytoprotective response against diabetes-induced
hepatorenal injury not only through recovery of the antioxidant defense system of the
cell, but also through a marked antiglycation activity.
Keywords: diabetes, Lactarius deterrimus, Castanea sativa, hepatorenal protection, antioxidant and antiglycating
activity
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INTRODUCTION
Diabetes mellitus (DM) type 1 is a metabolic disorder
characterized by a severe deficiency in insulin secretion
resulting from atrophy of the islets of Langerhans and causing
hyperglycemia that results from a disruption of insulin-
signaling because of insufficient insulin secretion. In many
tissues, increased glucose levels enhance oxidant production
that through interactions with non-enzymatic, enzymatic and
mitochondrial pathways can overwhelm cellular antioxidant
defenses, leading to chronic oxidative stress (King and Loeken,
2004). Perturbed insulin-signaling, elevated levels of blood
glucose and increased oxidant levels arising from different
sources, stimulate pathways that under physiological conditions
are either not expressed or are expressed at considerably
lower levels. These include stimulation of polyol pathway,
increased formation of AGEs (advanced glycation end-products),
increased expression of the receptor for AGEs (RAGE)
and its activating ligands, activation of protein kinase C
and overactivity of the hexosamine biosynthetic pathway
(HBP) (Mohora et al., 2007). These different pathways are
interrelated and in a pathological setting potentiate each other,
leading to excess production of compounds that cause cellular
damage by oxidizing membrane lipids, modifying intracellular
proteins and their functions and inducing DNA damage.
Ultimately, all these process are involved in the development
of diabetic pathologies (Giacco and Brownlee, 2010) that
results from microvascular (diabetic retinopathy, nephropathy,
and neuropathy) and macrovascular complications (ischemic
heart disease, cerebrovascular and peripheral vascular disease).
Also, diabetes is estimated to be the most common cause of
oxidative stress-related liver disease (Rutter, 2000; Guven et al.,
2006).
Glucose control and the selective use of antioxidants
with defined modes of action suppress the activation of
oxidative stress-related pathways and delay the progression
of diabetes-related complications. Established antioxidants
such as N-acetylcysteine, vitamins C and E, and α-lipoic
acid have been shown to be moderately effective in reducing
certain diabetic complications, which points to an overall
beneficial effect of antioxidant intake in diabetes (da Silva
et al., 2010; Arambasic et al., 2013; Dinic et al., 2013).
Several reports have shown that as might logically be
anticipated, combinations of different antioxidants are
superior to monotherapy (Kowluru and Kennedy, 2001).
For that account many plant extracts and plant products
have been viewed as promising therapeutic drug in the
prevention of different pathologies linked to oxidative stress
(Saeed et al., 2012). This is because the levels of phenolic
and flavonoid compounds, highly present in plant extracts,
correlate positively with its antioxidant capacity which
manifests as free radical scavenging, metal ion chelation,
hydrogen donation and reducing activities (Diaz et al.,
2012). Several studies have also demonstrated that the
phenolic content of plant extracts correlates with its anti-
glycation activity (Harris et al., 2011), and that a wide
range of other non-phenolic compounds such as terpenes,
carotenoids, polyunsaturated fatty acids, and polysaccharides
are capable of reducing non-enzymatic protein glycosylation
(Sun et al., 2010). As purified bioavailable phenolic and
flavonoid compounds are difficult to obtain, and because
extracts have better antioxidant activities than their individual
components (Calliste et al., 2005), there is a growing interest
for assessing the effects and considering the potential use of
plant extracts containing complex mixtures of different bioactive
molecules.
Sweet chestnut tree from the Fagaceae family, which
grows in the Mediterranean region of Europe, is a known
source of phenolic bioactive compounds, in particular of
tannins (Sanz et al., 2010). It has been widely used in
folk medicine for treating various respiratory diseases and
recent studies have shown that the Castanea sativa extract
possesses antiviral (Lupini et al., 2009) and antioxidant
effect (Frankicˇ and Salobir, 2011; Mujic´ et al., 2011) as
well as the ability to prevent DNA damage (Grdovic´
et al., 2012). Edible and medicinal mushrooms have
various biological activities and for centuries have been
used in prevention and treatment of various diseases
(Lindequist et al., 2005). Edible mushrooms and their
constitutive active compounds have been described to have
antioxidant properties and therefore are important in the
management of diabetes (Yamac et al., 2008; Lo and Wasser,
2011). Lactarius deterrimus, also known as false saffron
milkcap or orange milkcap, from the family Russulaceae is
distributed in Europe, but has also found in parts of Asia.
Lactarius species have been reported to exhibit a variety of
biological activities including antitumor, antioxidant, and
immunostimulant activity (Athanasakis et al., 2013; Hou et al.,
2013).
In our previous works, we described the antioxidant
properties and beneficial effects of extracts obtained from
the edible mushroom Lactarius deterrimus (Ld), the spiny
burrs of the sweet chestnut Castanea sativa (Cs) and
their combination (MIX Ld/Cs), on streptozotocin (STZ)-
induced rat pancreatic β-cell death in vitro (Mujic´ et al.,
2011; Grdovic´ et al., 2012). We observed that the strong
antioxidant effect of the Cs extract corresponded to the
high content of phenolic and flavonoid compounds, while
the Ld extract with a low phenolic and flavonoid content
had only a moderate antioxidant effect. However, the
combination of these extracts (MIX Ld/Cs) significantly
increased β-cell viability in vitro after the STZ treatment
as a result of the significant reduction of DNA damage
and improved redox status. We concluded that improved
cytoprotection provided by MIX Ld/Cs was the consequence of
additive and synergistic effects of the different antioxidant
activities, contained in the chestnut and mushroom
extracts. To lend credence to the potential in vivo beneficial
biological effects of the mushroom and chestnut extracts,
we investigated the effect of their daily administration for
4 weeks, either separately (Cs or Ld) or combined (MIX
Ld/Cs), on the pathways responsible for redox homeostasis
maintenance in the liver and kidney of STZ-induced diabetic
rats.
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MATERIALS AND METHODS
Chestnut and Mushroom Material and
Extraction Procedures
The mushroom Lactarius deterrimus (Ld) was collected in the
Istra region in Croatia, in the summer of 2008. Fruiting bodies
were gently cleansed of any residual compost, air-dried and
stored in airtight plastic bags at room temperature. Samples of
spiny burrs of the sweet chestnut (Cs) (C. sativa Mill.) were
collected in western Bosnia and Herzegovina. The chestnut
samples were collected during the chestnut-ripening season,
from the middle of September to the end of October 2006.
The collected samples were kept at −20◦C and protected from
light before further use. The dried mushroom samples and
chestnut samples (spiny-burrs) was obtained from Dr. Senka
Vidovic´ (Faculty of Technology, University of Novi Sad) The
dried samples were milled in a blender before extraction with
50% ethanol, at a sample:solvent ratio of 1:10 (w/v) for the
mushroom extract, and 1:5 (w/v) for the chestnut extract. The
extraction process was carried out using an ultrasonic bath (B-
220; Branson and SmithKline Company) at 45◦C for 40 min for
the mushroom extract, and at room temperature for 30 min for
the chestnut extract. After filtration, the extraction solvent was
removed using a rotary evaporator (Devarot; Elektromedicina)
under vacuum. The obtained extracts were dried at 60◦C to a
constant mass and stored in glass bottles at −80◦C to prevent
oxidative damage.
Phytochemical Analysis of Castanea
sativa and Lactarius deterrimus Extracts
The contents of total phenolic compounds in the dry mushroom
and chestnut extracts were determined by the Folin–Ciocalteu
procedure at 765 nm (Singleton and Rossi, 1965). The values
are expressed as mg of gallic acid equivalents (GAE) per
1 g of dry extract. The Cs and Ld extracts contained
252 and 14.8 mg gallic acid per gram of dry material,
respectively, in total phenolics. The total flavonoid contents
were established by the aluminum-chloride colorimetric assay
at 510 nm (Markham, 1989). The values are expressed as
mg of quercetin equivalents (QE) per 1 g of dry extract.
The flavonoid contents in the Cs and Ld extracts were 192
and 5.07 mg quercetin per gram of dry material, respectively.
Previous detailed qualitative and quantitative analyses of the
extract by High-Performance Liquid Chromatography with
Diode-Array Detection (HPLC/DAD) revealed in Cs extract the
highest content of ellagic acid structures, followed by gallic acid
derivatives and flavonoid structures (Grdovic´ et al., 2012). In
the Ld extract, compounds containing a phenolic group were
tryptophan and p-hydroxybenzoic acid, while other detected
compounds were unsaturated and oxy (hydroxy- or epoxy-) fatty
acids (Grdovic´ et al., 2012).
Experimental Protocol
Experiments were performed on 2.5-month-old adult albino
Wistar rats weighing 220–250 g. All animal procedures were
approved by the Committee for Ethical Animal Care and
Use of the Institute for Biological Research “Siniša Stankovic´,”
University of Belgrade, which acts in accordance with the EEC
Directive (86/609/EEC) on the protection of animals used for
experimental and other scientific purposes. The experimental
model of multiple low-dose STZ-induced diabetes was used.
Diabetes was induced by intraperitoneal (i.p.) injections of 40 mg
STZ/kg to Wistar rats for 5 consecutive days. STZ was dissolved
immediately before use in sodium citrate buffer (0.1 M, pH 4.5).
Blood glucose was measured 24 h after the last STZ injection.
Blood samples were obtained from the tail vein of overnight-
fasted rats, and glucose was measured with a blood glucometer
(Accu-Chek Active). Rats were considered to have diabetes when
the fasting blood glucose level exceeded 20 mmol/l. Male Wistar
rats were randomly divided into five groups: (i) ND – the non-
diabetic control group (n = 7) which received an equivalent
volume of citrate buffer i.p. for 5 consecutive days; (ii) D – the
diabetic group (n = 8) that received STZ (40 mg/kg/5 days,
i.p.) and was left untreated throughout the 4-week period; (iii)
D + Cs – the diabetic group treated with the chestnut extract
(Cs; 60 mg/kg, i.p.) daily for 4 weeks (n = 8), starting from
the last day of STZ administration; (iv) D + Ld – the diabetic
group treated with the mushroom extract (Ld; 60 mg/kg, i.p.)
daily for 4 weeks (n = 8), starting from the last day of STZ
administration; (v) D + Cs/Ld – the diabetic group treated with
the combination of chestnut and mushroom extract (Mix Cs/Ld;
60 + 60 mg/kg, i.p.) daily for 4 weeks (n = 8), starting from the
last day of STZ administration. The mode of administration was
chosen to be i.p. because rats refused to drink the extract due
to its bitterness. Based on our previous experimental experience,
we estimated that i.p. administration is less stressful for the rats
than force-feeding by gavage and it ensures that animal receive
the desired dose. Even dough, the i.p. delivery is considered
a parenteral route of administration, the pharmacokinetics of
substances administered intraperitoneally are more similar to
those seen after oral administration (Turner et al., 2011) as
well as the bioavailability of substances is higher. The rats were
killed 4 weeks after diabetes was established. Following blood
collection, an abdominal incision was made and the liver and
both kidney were removed and processed further as indicated.
The remaining liver and kidney tissue was frozen in liquid
nitrogen, kept at −80◦C and used for cytoplasmic and nuclear
protein preparation according to the instructions described
in ProteoJET cytoplasmic and nuclear protein extraction kit
(Fermentas).
Determination of Biochemical
Parameters of Diabetes and Histological
Analysis of Liver and Kidney Tissue
After 4 weeks of diabetes, the rats were fasted overnight and
their blood was collected in heparinized tubes (1,000 IU heparin).
Blood plasma was obtained after centrifugation at 2,000 × g for
10 min and used for determination of glucose, total cholesterol,
triglycerides, aspartate and alanine aminotransferases (AST and
ALT, respectively), and blood urea nitrogen (BUN). After
centrifugation and collection of plasma fractions, the remaining
pellets were used for the preparation of red blood cell (RBC)
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hemolysates. RBC were washed twice with 0.9% NaCl and lysed
in three volumes of cold water for 30 min on ice. Hemolysates
were used for the determination of glycated (Gly) hemoglobin
(Hb).
Blood glucose concentrations were measured with
a commercial kit (Gluco-quant Glucose/HK, Boehringer
Mannheim, Germany), which is based on the hexokinase/G6P-
DH enzymatic method. Concentrations of GlyHb were
determined by the colorimetric assay according to Parker
et al. (1981). Serum triglyceride concentrations were determined
by the glycerol-3-phosphate (GPO) oxidase-p-aminiphenazone
(PAP) method with an enzymatic kit (Randox Laboratories,
United Kingdom). Total cholesterol concentrations were
measured by the enzymatic cholesterol esterase-cholesterol
oxidase method using the CHOD-PAP test kit (Randox
Laboratories, Crumlin, United Kingdom). Activities of ALT and
AST were estimated by measuring the produced oxaloacetate and
pyruvate, respectively, using an optimized standard UV kinetic
method kit [GPT (ALAT) IFCC mod.; GOT (ASAT) IFCC mod.].
Blood urea nitrogen level was estimated according to GLDH
method (Human, Wiesbaden, Germany).
The liver and kidney tissue from all experimental groups were
removed and fixed in 10% buffered formalin for histological
examination. Liver and kidney tissues from all examined groups
were embedded in paraffin wax and sectioned at 5 mm thickness
for histological examination. For histological analysis tissue
sections were stained with Hematoxylin (H) and Eosin (E),
mounted and observed under a light microscope (Leica DMLB;
objective magnification 20×).
Estimation of Oxidative Stress
The level of oxidative stress in liver and kidney tissue was
estimated by using 2′,7′-dichlorofluorescin diacetate (DCFDA),
a fluorogenic dye that measures hydroxyl, peroxyl, and other
reactive oxygen species (ROS) activity. Briefly, an aliquot of
the liver and kidney homogenates (0.01 ml) were mixed with
0.15 ml ethanol solution of DCFDA to the final concentration
of 10 mM. After incubation for 30 min at RT and in dark the
fluorescence was measured using Tecan microplate reader Safire
II (excitation and emission wavelengths of 488 and 520 nm,
respectively).
Thiobarbituric Acid-Reactive Substance
(TBARS) Assay
Lipid peroxidation was examined with the TBARS assay
according to Ohkawa et al. (1979). Briefly, an aliquot of the
liver and kidney homogenates (0.1 ml) prepared in 1.15 M KCl
were mixed with 0.2 ml of 8.1% SDS, 1.5 ml of 20% acetic
acid (pH 3.5), 1.5 ml of 0.8% TBA, and 0.7 ml water and
heated at 95◦C for 60 min. After cooling to room temperature,
1 ml of water and 5 ml of n-butanol/pyridine (15:1, v/v)
were added, mixed and centrifuged at 3,000 × g for 10 min.
The red pigment in the supernatant fractions was estimated
by absorbance at 532 nm. A calibration curve was prepared
with 1,1,3,3-tetramethoxypropan (concentrations ranged from
25 nmol/ml to 1 µmol/ml).
Comet Assay
The level of DNA damage was assessed by the alkaline
Comet assay (Singh et al., 1988). Liver and kidney samples
from all experimental groups were minced in ice-cold HBSS
buffer (0.14 g/l CaCl2, 0.4 g/l KCl, 0.06 g/l KH2PO4, 0.1 g/l
MgCl2 × 6H2O, 0.1 g/l MgSO4 × 7H2O, 8.0 g/l NaCl, 0.35 g/l
NaHCO3, 0.09 g/l Na2HPO4 × 7H2O, 1.0 g/l D-glucose)
containing 20 mM EDTA and 10% DMSO. Ten microliters of
a liver or kidney cell suspension was mixed with low-melting
agarose (0.75%) and applied to a microscope slide. Cells were
lysed for 2 h at 4◦C in lysis buffer (2.5 M NaCl, 100 mM EDTA,
10 mM Tris, pH 10, 1% Triton X-100). After lysis, the slides were
incubated for 30 min at 4◦C in electrophoresis solution (300 mM
NaOH, 1 mM EDTA, pH 13.0) and subjected to electrophoresis
in order to separate the damaged DNA fragments. The slides
were placed in neutralization buffer (0.4 M Tris-HCl, pH 7.4)
and stained with SYBR Green I (1:10,000 dilution; Sigma–
Aldrich). Fluorescence microscopy was performed with a Zeiss
Axiovert 135TV microscope equipped for epifluorescence. DNA
damage was quantified by measuring the displacement between
the genetic material contained inside the nuclear sphere or comet
‘head’ and the resulting comet ‘tail.’ Images were analyzed with
TriTekCometScore Freeware v1.5.1
Formation of Fructosamines during
in Vitro Glycation
Reaction mixtures containing bovine serum albumin (BSA)
(20 mg/ml)/glucose (1 M)/fructose (1 M) system (1 ml), dissolved
in 20 mM Tris-HCl (pH 7.4), in the presence or absence of
examined extracts were incubated at 37◦C for 7 days (Brownlee
et al., 1986). The incubated solution was mixed with 0.5 mM
NBT (0.5 ml) dissolved in 100 mM carbonate puffer pH 10.8.
The reduction of NBT was measured at 595 nm according to the
formula: %Inhibition = ((Ablank − Atest)/Ablank) × 100, where
Ablank is the absorbance of the BSA/glucose system without the
test sample, and Atest is the absorbance of BSA/glucose system in
the solution with the test sample.
AGE Formation in Vitro
Bovine serum albumin (20 mg/ml) was incubated with glucose
(1 M) and fructose (1 M) in Tris-HCl pH 7.4 containing 0.02%
sodium azide. All of the reagents and the examined extracts
were passed through filter paper and each of the mixtures
was incubated at 37◦C for 7 days. The formation of AGE
was measured by the fluorescence intensity at an excitation
wavelength of 330 nm and an emission wave-length of 410 nm
with a Luminescence spectrometer LS50B (PerkinElmer Ltd.,
Buckinghamshire, England) (Lee et al., 1998).
Determination of Superoxide Dismutase
(SOD) and Catalase (CAT) Activities
For determination of antioxidant enzyme activities, a
homogenate of fresh liver and renal tissue was prepared
in sucrose buffer (0.25 M sucrose, 1 mM EDTA, 0.05 M
1http://www.AutoComet.com
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Tris-HCl, pH 7.4). Firstly, 1 g of liver and kidney tissue was
homogenized in 10 ml of sucrose buffer, sonicated, and at
the end centrifuged at 100,000 × g in a Beckmann rotor
Ti 50 for 90 min. Total SOD activity was measured by the
epinephrine method (Misra and Fridovich, 1972). SOD activity
was expressed as U/mg of protein. MnSOD activity was
performed after preincubation with 8 mmol/l KCN. CuZnSOD
activity was calculated from the difference between total SOD
and MnSOD activities. CAT activity was measured by the rate
of hydrogen peroxide decomposition and expressed as l M
H2O2/min/mg protein (U/mg of protein) (Claiborne, 1984).
Protein concentrations were determined according to Lowry
et al. (1951).
Determination of Reduced to Oxidized
Glutathione Ratio (GSH/GSSG)
Total GSH and GSSG levels were determined by the standard
recycling method using the Glutathione Assay Kit (Cayman
Chemicals Company, Ann Arbor, MI, United States). A 20%
homogenate of fresh liver and renal tissue was prepared in
phosphate buffer (100 mM NaH2PO4, 1 mM EDTA, pH 7.5).
Samples for GSSG determination were incubated at room
temperature with 2 µl of 0.5 M 2-vinyl pyridine solution per 50 µl
of deproteinized sample for 1 h. Samples were deproteinized
with 5% 5-Sulfosalicylic acid solution. Incubation with 2-vinyl
pyridine conjugates any GSH present in the sample so that only
GSSG is recycled to GSH. The GSSG was then subtracted from
the total GSH to determine the actual GSH level and GSH/GSSG
ratio.
Sodium Dodecyl Sulfate
(SDS)–Polyacrylamide Gel
Electrophoresis (PAGE) and Immunoblot
Analysis
For immunoblot analysis, homogenates of fresh liver and renal
tissue prepared in sucrose buffer were used. Twenty micrograms
of liver and kidney protein fractions were separated onto
4% stacking/12% separating slab gels. After electrophoresis,
proteins were transferred to PVDF membranes (Hybond-P,
Amersham Pharmacia Biotech) and immunoblot analysis was
performed using rabbit polyclonal antibodies to O-linked
β-N-acetylglucosamine (O-GlcNAc), N-(carboxymethyl)lysine
(CML), RAGE, nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB) p65, β-actin; goat polyclonal anti-
bodies to lamin B (Santa Cruz Biotechnology, Santa Cruz,
CA, United States). Appropriate horseradish peroxidase-
conjugated anti-rabbit, anti-goat (Santa Cruz Biotechnology,
Santa Cruz, CA, United States), and anti-mouse (Cell Signaling)
immunoglobulins were used as a secondary antibody. Each
PVDF membrane was reprobed according to the supplier’s
protocol for reprobing. Immunoreactive bands were identified
by an enhanced chemiluminescence (ECL) detection system
(Santa Cruz Biotechnology) according to the manufacturer’s
instructions. The blots were scanned, and the intensities of the
signals were quantified using TotalLab (Phoretix, Newcastle
Upon Tyne, England) electrophoresis software (ver. 1.10).
Statistical Analysis
The data were expressed as the mean ± SEM (standard error
of mean). Before statistical analysis we tested the obtained data
for normality using a Kolmogorov–Smirnov test. For intergroup
comparison between two means, first a one-way Analysis of
Variance (ANOVA) was used and in case of significance a
Duncan’s multiple range test (DMRT) was applied as a post
hoc test. The difference was considered statistically significant at
p < 0.05. Mann–Whitney test was used in one particular case
(for total amount of Nf-kB) to compare differences between two
independent groups (p< 0.05).
RESULTS
The Effects of Extracts on the
Biochemical Parameters and
Histological Features of Liver and Kidney
Tissue in Diabetic Rats
The biochemical markers of diabetes in different experimental
groups are presented in Table 1. Compared to the control non-
diabetic rats, the STZ-treated animals displayed typical signs
of diabetes: elevated fasting blood glucose and total glycated
hemoglobin level (5- and 2-fold, respectively), as well as increased
total cholesterol and triglyceride concentrations (1.6- and 1.9-
fold, respectively). The activation of detrimental processes in
the liver and kidney of diabetic rats was observed as increased
enzymatic activities of ALT and AST, markers of hepatocellular
injury, and increased BUN, an indicator of renal functionality.
The treatment of diabetic rats with Cs extract lowered fasting
blood glucose, GlyHb, cholesterol, triglyceride and ALT levels to
the control values and significantly lowered the concentration
of BUN. In contrast, the treatment of diabetic rats with the Cs
extract did not cause any significant change in AST activity.
Administration of the Ld extract to diabetic rats alleviated
hyperglycemia, decreased GlyHb and triglyceride levels and
restored the total cholesterol concentration to the control values.
While the treatment of diabetic rats with the Ld extract improved
the enzymatic activity of AST, the level of ALT activity and BUN
concentration remained elevated. Diabetic rats treated with the
combination of the mushroom and chestnut extracts MIX Ld/Cs
displayed improvements in all measured parameters, indicating
a better glycemic and lipid status and improved liver and kidney
functioning.
Figure 1 depicts the photomicrographs of hematoxylin and
eosin staining of liver and kidney tissues of control and
experimental groups of rats. ND control rats showed liver
parenchyma with general structures preserved, including hepatic
lobules with normal hepatocytes surrounded by sinusoids and
distributed radially toward the centrilobular veins with no
observed inflammatory infiltration and fatty degeneration. In
contrast, untreated D rats presented morphological changes in
the liver that were characterized by hepatocytes that contained
focal or generalized fatty vacuoles and micro- or macro vesicular
features that were associated with the presence of dilated
sinusoids and a progressive loss of general organ structure
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TABLE 1 | Effect of Castanea sativa, Lactarius deterrimus, and their combination on biochemical parameters in streptozotocin (STZ)-induced diabetic rats.
ND D D + Cs D + Ld D + Cs/Ld
Glucose (mmol/L) 6.2 ± 0.22a 30.1 ± 1.12b 6.2 ± 0.25a 22.7 ± 0.94c 19.6 ± 0.91c
GlyHb (mmol/gHb) 6.5 ± 0.26a 11.6 ± 0.51b 7.7 ± 0.32a 9.1 ± 0.41c 8.7 ± 0.38c
Cholesterol (mmol/L) 1.6 ± 0.07a 2.6 ± 0.11b 1.7 ± 0.05a 1.6 ± 0.04a 1.9 ± 0.09c
Triglycerides (mmol/L) 0.7 ± 0.03a 1.4 ± 0.06b 0.7 ± 0.02a 1.0 ± 0.05c 1.1 ± 0.04c
AST (U/L) 199.1 ± 4.5a 284.1 ± 7.2b 267.4 ± 5.5b 250.4 ± 6.3c 255.3 ± 5.2c
ALT (U/L) 58.6 ± 1.6a 113.3 ± 3.4b 59.4 ± 1.5a 116.4 ± 3.5b 90 ± 2.9c
BUN (mmol/L) 6.8 ± 0.26a 14.6 ± 0.65b 12.3 ± 0.52c 14.35 ± 0.6b 11.9 ± 0.45c
ND, non-diabetic rats; D, diabetic rats; Cs, Castanea Sativa; Ld, Lactarius deterrimus.
Values are means ± SEM; values not sharing a common superscript letter differ significantly at p < 0.05 (Duncan’s multiple range test, DMRT).
(disorganization of the lobular architecture) together with
mild inflammatory cell infiltration. Histological examination
of the livers of diabetic rats treated with Cs extract and
MixCs/Ld maintained normal lobular architecture and had mild
fatty change, feathery degeneration, and only slight neutrophil
infiltration almost comparable to the normal. Also, Ld treatment
protected liver tissue from diabetes-induced damage, but to a
lesser extent.
The sections of kidney tissue of control rats demonstrated
normal architecture with normal glomeruli and tubules. On
the other hand, section of kidney tissues of diabetic group
of rats revealed visible distortion in the architecture of the
kidney tissue showing features of glomerulopathy such as
compression of the glomerular tuft into nodules with decreased
cellularity of the glomeruli, dilated tubules lined by cuboidal
epithelium without brush borders and marked inflammatory
cells infiltration. However, the treatment of diabetic rats with
Cs extract and MixCs/Ld attenuated the histological changes
in the kidney of diabetic rats showing better patterned renal
architecture with fairly normal glomeruli and tubules and mild
inflammatory cells infiltration. Also, Ld treatment attenuated
kidney damage, but to a lesser extent.
The Beneficial Effects of Extracts on
Hyperglycemia-Induced Oxidative Stress
in the Liver and Kidney of Diabetic Rats
To estimate the level of oxidative stress we used a non-fluorescent
substrate 2′,7′-dichlorofluorescein (DCFDA) which undergoes
oxidation to green fluorescent product in the presence of ROS.
The highest level of oxidative stress, based on the measured
fluorescence, was detected in the liver and kidney of diabetic
animals (Figure 2A). On the other hand, in the liver and
kidney tissue of diabetic animals treated with the extracts,
separately and in combination, the extent of ROS production was
significantly lower. The strongest effect on the ROS production
in both examined tissues was displayed by mushroom extract
(Figure 2A).
The end products of lipid peroxidation are reactive aldehydes,
such as MDA, which served as an indicator of lipid peroxidation
in liver and kidney in each experimental group (Figure 2B).
Highest concentration of MDA equivalents (MDAeq), measured
using the thiobarbituric acid-reactive substance assay, were
detected in the liver and kidney of diabetic rats. Comparison of
MDAeq levels in the liver and kidney of diabetic animals and
the diabetic animals treated with the extracts revealed that both
extracts, as well as MIX Ld/Cs, exhibited statistically significant
inhibition of lipid peroxidation. The mushroom extract showed
the highest potential for inhibition of lipid peroxidation, based
on the MDAeq level that was 2-fold lower than in the liver of
diabetic rats and 1.6-fold lower than in the kidney of diabetic
rats. The chestnut extract and the combination of extracts
were less effective, as they both induced a 1.4-fold decrease of
MDAeq in both liver and kidney when compared to diabetic rats
(Figure 2B).
Oxidative damage to DNA in the liver and kidney in each
experimental group was evaluated by the alkaline Comet assay
(Figures 2C,D). The extent of DNA damage was expressed as
% of DNA in comet’s tail (Figure 2D). Representative images
of liver and kidney cells whose DNA was visualized by staining
with SYBR Green I are shown in Figure 2C. In the control, non-
diabetic group, the majority of analyzed liver and kidney cells
did not exhibit DNA damage (Figure 2C, ND panels). In STZ-
induced diabetic rats, extensive DNA damage was observed in
liver and kidney cells. This was revealed by the large amount of
DNA in the comet tails (Figures 2C,D panels). Treatments of
diabetic animals with the extracts, separately and in combination,
led to a pronounced decrease in DNA damage in liver and kidney
cells (panels D + Cs, D + Ld, and D + Cs/Ld). Analysis of
% of DNA in comet’s tail revealed that the mushroom extract
and the combination of the extracts provided the best protection
against diabetes-induced DNA damage in liver cells (Figure 2D).
On the other hand, in kidney cells, the chestnut extract and
the combination of the extracts caused the greatest decrease in
DNA damage (Figure 2D). Taken together, these results indicate
that both extracts and their combination significantly suppressed
oxidative stress and thereby oxidative damage of lipids and DNA
in liver and kidney tissue of diabetic animals.
To determine whether the observed suppression of oxidative
stress after the treatment with extracts was caused by changes
in activities of antioxidant enzymes, we examined the activities
of MnSOD, CuZnSOD, and CAT. As can be seen in Figure 3,
STZ-induced diabetes was associated with significantly decreased
MnSOD, CuZnSOD, and CAT activities in liver and kidney
tissue. The treatment of diabetic rats with both extracts separately
and in combination promoted increased activity of MnSOD to
nearly control level in both examined tissues, except in the case
of Cs-treated animals where the level of liver MnSOD activity
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FIGURE 1 | The effect of Castanea sativa, Lactarius deterrimus extracts and their combination on the histological changes in liver and kidney tissue of diabetic rats.
H&E-hematoxylin and eosin staining of liver and kidney sections (magnification 20×); ND, non-diabetic control rats; D, diabetic rats; D + Cs, diabetic rats treated with
C. sativa; D + Ld, diabetic rats treated with L. deterrimus; D + Cs/Ld, diabetic rats treated with the combination of C. sativa and L. deterrimus extract; G, glomerulus;
T, tubules.
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FIGURE 2 | The effect of C. sativa, L. deterrimus extracts and their combination on the level of oxidative stress and oxidative damage of lipids and DNA in liver and
kidney tissues. (A) Oxidative stress was estimated by 2′,7′-dichlorofluorescin diacetate (DCFDA). (B) Lipid peroxidation was estimated by the thiobarbituric
acid-reactive substance (TBARS) assay. (C) Representative images of DNA damage assessed by the alkaline Comet assay. (D) Assessment of DNA damage using
% of DNA in comet’s tail as a parameter of DNA damage. ND, non-diabetic control rats; D, diabetic rats; D + Cs, diabetic rats treated with C. sativa; D + Ld, diabetic
rats treated with Lactarius deterrimus; D + Cs/Ld, diabetic rats treated with the combination of C. sativa and L. deterrimus extract. Results are expressed as
mean ± SEM. Means not sharing a common letter are significantly different between groups (Duncan’s multiple range test, DMRT; p < 0.05).
remained below its control level (Figure 3A). Treatment of
STZ-diabetic rats with the Ld extract and MIX Ld/Cs restored
the activity of liver and kidney CuZnSOD to the control levels
(Figure 3B). However, the chestnut extract caused a significant
increase of CuZnSOD activity which was 18 and 14% below
its control values in the liver and kidney, respectively. In
contrast to the restoration of SOD activities, the treatments of
diabetic rats with Cs, Ld, and MIX Ld/Cs did not produce any
effect on CAT activity in the liver and kidney of diabetic rats
(Figure 3C).
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FIGURE 3 | The effect of C. sativa, L. deterrimus extracts and their combination on the activities of antioxidant enzymes MnSOD (A), CuZnSOD (B), catalase (CAT)
(C) and reduced to oxidized glutathione ratio (GSH/GSSG) (D) in liver and kidney tissue. ND, non-diabetic control rats; D, diabetic rats; D + Cs, diabetic rats treated
with C. sativa; D + Ld, diabetic rats treated with L. deterrimus; D + Cs/Ld, diabetic rats treated with the combination of C. sativa and L. deterrimus extract. Results
are expressed as means ± SEM. Means not sharing a common letter are significantly different between groups (DMRT; p < 0.05).
During oxidative stress, the concentration of GSH decreases
and is accompanied by an increase in its oxidized form (GSSG).
A significant decrease in the GSH/GSSG ratio was detected
in the liver and kidney of diabetic rats as compared to non-
diabetic controls (Figure 3D). The treatment of diabetic rats with
either extract or their combination shifted the redox balance of
glutathione in favor of its reduced form in both tissues, except
in kidney tissue of Ld-treated rats. The strongest effect on the
GSH/GSSG ratio in both tissues was displayed by MIX Ld/Cs
(Figure 3D).
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FIGURE 4 | The effect of C. sativa, L. deterrimus extracts and their
combination on non-enzymatic glycation in vitro. (A) Formation of
fructosamines in the presence of different concentrations of examined
extracts measured by NBT assays. (B) Formation of advanced glycation
end-product (AGE) in the bovine serum albumin (BSA)/glucose/fructose
system in the presence of different concentrations of extracts. The values are
means ± SEM from three separate experiments.
Evaluation of the Antiglycation
Properties of the Examined Extracts
in Vitro
We examined the potential inhibitory effects of the separate
extracts and their combination on the formation of fructosamines
during the process of protein glycation. This was studied by
monitoring the reduction of NTB on the 7th day of incubation in
the BSA/glucose/fructose system in the presence or absence of the
examined extracts. The concentration ranges differed for the two
extracts and were previously defined (Grdovic´ et al., 2012). As can
be seen on Figure 4A, the inhibition of NBT reduction, which is
directly related to the ability of the examined extracts to suppress
glycation, was dose-dependent in the case of both extracts, while
the combination of the two extracts exhibited the strongest
anti-glycation activity, providing nearly 80% inhibition of NBT
reduction (Figure 4A). The formation of AGE was monitored by
measuring the fluorescence intensity of the BSA/glucose/fructose
solution attributed to the formation of glycophore groups. As
shown in Figure 4B, when the extracts were added to the reaction
media containing the BSA/glucose/fructose system, a significant
concentration-dependent reduction in fluorescence intensity was
observed at the end of study period. Again, the combination of
different extracts displayed the greatest effect, inhibiting AGE
formation by 90%.
Effects of the Examined Extracts on
Non-enzymatic Protein Glycation and
AGE-Mediated Pathways in the Liver and
Kidney of Diabetic Rats
After establishing that both extracts inhibit protein glycation and
AGE formation in vitro, we investigated in vivo protein glycation
in the liver and kidney. We observed increased protein glycation
in both the liver and kidney of diabetic rats in comparison to
the control glycation levels (Figure 5A). Treatments of diabetic
rats with the Cs, Ld, and MIX Ld/Cs significantly diminished
the amount of glycated proteins in both examined tissue. In liver
tissue, the combination of the Cs and Ld extracts provided the
best protection against diabetes-induced protein glycation, while
in kidney tissue all three treatments decreased glycated proteins
to a similar level.
Reactive derivatives of non-enzymatic glucose-protein
condensation reactions form a heterogeneous group of
irreversible adducts called AGE, which refers to a broad
range of advanced products of the Maillard reaction (Reinauer,
1993), including stable AGE compounds such as CML. As
expected, immunostaining for CML revealed that diabetic rats
exhibited significantly elevated AGE levels in the liver and kidney
as compared to non-diabetic controls (Figure 5B). Densitometric
analysis of the electrophoretic protein profiles showed that the
treatment of diabetic rats with Ld, Cs, and MIX Ld/Cs reduced
CML immunostaining in both tissues to significantly lower levels
than in diabetic rats. The greatest reduction of CML was detected
in liver and kidney tissues of diabetic animals that were treated
with the Cs extract.
To examine whether the detected suppression of AGE
formation after treatment of diabetic rats with extracts affected
the RAGE-NF-κB axis, we performed immunoblot analysis
of liver and kidney tissues with anti-RAGE and anti-NF-κB
antibodies. Densitometric analysis of the bands obtained after
immunoblot analysis (Figure 6A) shows increased levels of
RAGE in liver and kidney homogenates of diabetic rats. This
increase was effectively prevented by treatments of diabetic
rats with the Ld and Cs extracts separately, as well as their
combination MIX Ld/Cs, in both examined tissue. Treatments
with either with Cs or MIX Ld/Cs manage to retain the
level of RAGE in both examined tissues at the control
level (Figure 6A). Since RAGE activation perpetuates NF-κB
activation, we examined the translocation of NF-κB p65 from
the cytosol to the nucleus (Figure 6B). Western blot analysis
revealed an overall increase in NF-κB p65 in liver and kidney
nuclear fractions of diabetic rats (observed as an approximate
nuclear:cytoplasmic p65 ratio >1), as compared to non-diabetic
controls (where the nuclear:cytoplasmic p65 ratio< 1). While the
cellular distribution of p65 changed, the amount of total p65 was
not significantly altered in the livers of diabetic rats. However, in
the kidney of diabetic rats, the amount of total p65 was higher
than in control kidney. Administration of the extracts to diabetic
rats produced varied responses. In the liver, their administration
lowered the amount of total p65 significantly below the control
level, with Cs producing the most pronounced decrease. Also,
administration of extracts led to significant decrease of p65
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FIGURE 5 | The effect of C. sativa, L. deterrimus extracts and their combination on protein glycation and formation N-(carboxymethyl)lysine (CML)-modified proteins
in liver and kidney tissue. (A) Glycation of serum proteins measured by the fructosamine assay. (B) Immunoblot analysis of CML-modified proteins in whole liver and
kidney homogenates. ND, non-diabetic control rats; D, diabetic rats; D + Cs, diabetic rats treated with C. sativa; D + Ld, diabetic rats treated with L. deterrimus;
D + Cs/Ld, diabetic rats treated with the combination of C. sativa and L. deterrimus extracts. Results are expressed as means ± SEM. Means not sharing a
common letter are significantly different between groups (DMRT; p < 0.05).
in the liver nuclear fraction of diabetic rats, In the kidney,
Cs administration in diabetic animal effectively lowered the
relative amount of total p65 to the control level, bringing the
nuclear:cytoplasmic p65 ratio <1. While Ld administration was
less effective in lowering the relative amount of total p65, it also
shifted the nuclear:cytoplasmic p65 ratio<1. The administration
of MIX Ld/Cs had no effect in lowering the relative amount of
total p65, but it shifted the nuclear:cytoplasmic p65 ratio <1.
In addition to the AGE/RAGE pathway, we examined
weather changes in AGE formation influenced enzymatic protein
O-GlcNAcylation. To that end, we performed immunoblot
analysis of liver and kidney homogenates with anti-O-GlcNAc
antibody. Representative immunoblots for liver and kidney tissue
are shown in Figures 7A,B, respectively. Densitometric analysis
showed an increased level of total protein O-glycosylation in
both tissue of diabetic rats (Figures 7A,B). The treatments of
diabetic rats with the extracts significantly reduced the amount of
protein O-glycosylation in both organs. The greatest reduction of
O-GlcNAc proteins was detected in diabetic rats treated with the
combination of mushroom and chestnut extracts. The observed
changes in the level of O-GlcNAc proteins were most apparent
in the band indicated as p135, which has been identified as
O-N-acetylglucosamine transferase (Konrad et al., 2001; Zraika
et al., 2006). Densitometric analysis of the protein band at
135 kDa showed a similar pattern of change as total O-GlcNAc
proteins. However, the reduction of p135 glycosylation in both
the liver and kidney of diabetic rats treated with Ld the extracts
was more pronounced than the reduction of total O-GlcNAc
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FIGURE 6 | The effect of C. sativa, L. deterrimus extracts and their combination on the RAGE/NF-κB axis in liver and kidney tissue. (A) RAGE protein levels in liver
and kidney homogenates and (B) p65 NF-κB protein levels in liver and kidney nuclear and cytosol fractions examined by immunoblot analysis. ND, non-diabetic
control rats; D, diabetic rats; D + Cs, diabetic rats treated with C. sativa; D + Ld, diabetic rats treated with L. deterrimus; D + Cs/Ld – diabetic rats treated with the
combination of C. sativa and L. deterrimus extract; c-cytosol; n-nucleus. Results are expressed as mean ± SEM. Means not sharing a common letter are
significantly different between groups (DMRT; p < 0.05); ∗ total amount of p65 NF-κB (nuclear + cytosol) significantly different compared to diabetic rats
(Mann–Whitney test, p < 0.05).
proteins with regard to their levels in untreated, diabetic
rats.
DISCUSSION
Chronic hyperglycemia, together with increased plasma
cholesterol and triglyceride concentrations in STZ-induced
diabetic rats, causes the generation of ROS which leads to
cumulative oxidative damage of tissues and organs, producing
long-term diabetic complications considered to be the major
causes of morbidity and mortality in human diabetic populations
(Lyra et al., 2006). In the present study, AST and ALT were used
as marker enzymes to assess the extent of liver damage (Kim
et al., 2006), while BUN served as a kidney injury biomarker
(Rouse et al., 2013). The observed increased plasma levels of
liver enzymes together with histological changes in liver tissue
of diabetic rats revealed mild hepatocellular injury and changes
in liver function (Kim et al., 2006), while the elevation of BUN
together with observed histological alterations in kidney tissue
points to renal dysfunction (Rouse et al., 2013). Hepatorenal
injury was caused by oxidative damage, revealed by the elevated
level of DCFDA estimated ROS production in diabetic rats
which lead to increased lipid peroxidation and DNA damage in
liver and kidney cells (Kakkar et al., 1995; Hulbert et al., 2007).
The significant decreases in antioxidant enzyme activities and
of the GSH/GSSG ratio suggest that oxidative stress-induced
perturbations of liver and kidney functions were the result of the
inability of the antioxidant defense systems to maintain redox
balance.
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FIGURE 7 | The effect of C. sativa, L. deterrimus extracts and their combination on the level of O-GlcNAc-modified proteins in liver (A) and kidney (B) tissue. The
abundance of O-GlcNAc modified proteins in whole liver and kidney homogenates was assessed by immunoblot analysis. ND, non-diabetic control rats; D, diabetic
rats; D + Cs, diabetic rats treated with C. sativa; D + Ld, diabetic rats treated with L. deterrimus; D + Cs/Ld, diabetic rats treated with the combination of C. sativa
and L. deterrimus extracts. Results are expressed as means ± SEM. Means not sharing a common letter are significantly different between groups (DMRT; p < 0.05).
The significantly lowered diabetic hyperglycemia and
alleviated dyslipidemia after administration of the Cs and Ls
extracts, either separately or together (MIX Ld/Cs), could be
attributed to the systemic antioxidant effects of the extracts and
their impact on pancreatic islets in diabetic rats. Our previous
immunohistological examination of the pancreas showed that Ld
administration to diabetic rats decreased islet destruction and
partially restored the number of insulin-positive cells (Mihailovic
et al., 2015), leading to better glycemic control, manifesting
as an improvement of GlyHb and the lipid status, particularly
after the Cs treatment. One reason for the lower effectiveness
of the combination of extracts (MIX Cs/Ld) as compared to
Cs alone in restoring glucose homeostasis could be due to the
specific proportion of the two extracts in the mixture (50% each).
Different ratios of Cs and Ld extracts could provide distinct
responses (Vieira et al., 2012), and the lack of synergistic or
additive effect may be due to the chemical nature and reactivity
of compounds present in the mixtures (Nedamani et al., 2014).
These compounds can suffer polymerization and other reactions
causing structural alterations that result in changed antioxidant
activities (Pinelo et al., 2004). On the other hand, treatment
of diabetic rats with MixCs/Ld improved all three markers
of hepatorenal function (AST, ALT, and BUN), Cs treatment
improved two (ALT and BUN) and Ld treatment one (AST).
The improvement of hepatorenal function and structure in
extract-treated diabetic rats was associated with recovery of the
antioxidant defense systems. This was observed as, enhanced
levels of antioxidant enzymes MnSOD and CuZnSOD, an
improved GSH/GSSG ratio, and decreased oxidative damage
of lipids and DNA, with the MIX Ld/Cs providing the best
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protection. The effect on GSH, the first line of defense against
ROS, shifted the cellular redox balance of glutathione completely
in favor of its reduced form in both tissues. GSH is also a cofactor
of several detoxifying enzymes that provide the second line of
antioxidant defense by detoxifying harmful byproducts generated
by ROS and preventing the propagation of free radicals (Masella
et al., 2005). The overall improvement of the antioxidant defense
systems can also be attributed to the direct antioxidant effects
of the extracts. Our previous work showed that the powerful
antioxidant effect of the Cs extract was linked to the high content
of phenolics and flavonoids (Grdovic´ et al., 2012), and for the
Ld extract, it was assumed that the enrichment in essential trace
elements, such as Se and Zn, could have been responsible for the
described beneficial antioxidant effect of the mushroom extract
(Grdovic´ et al., 2012). Further, edible mushrooms contain an
abundance of functional components such as β-glucans (Manzi
and Pizzoferrato, 2000) that play an important role in the
recovery of the antioxidant defense system in the liver and kidney
of diabetic rats (Mihailovic et al., 2013a).
Phenolic metabolites with antioxidant activities also mediate
the antiglycation activity of medicinal plants (Harris et al., 2011).
The phenolic-rich Cs extract (Grdovic´ et al., 2012) decreased
most efficiently the formation of fructosamines and total AGE in
an in vitro glycation process, which is consonant with its ability
to maintain fasting blood glucose at the control level in diabetic
rats, and to prevent AGE formation in blood where glycation
of long-lived proteins such as Hb contributes to vascular
damage and the development of diabetic complications. The
antiglycation properties of the examined extracts present a good
therapeutic potential in the treatment of diabetes (Ramasamy,
2006; Mihailovic et al., 2013b).
Oxidation, which accompanies glycation in vivo, supports
the formation of more permanent, irreversible chemical
modifications, such as the well-characterized CML that serves as
a marker of AGE (Chappey et al., 1997). We detected significantly
increased levels of CML in liver and kidney tissues of diabetic
rats. Because the liver has a pivotal role in AGE catabolism, the
consequence of impaired hepatic function could be an increase in
the levels of circulating AGEs which leads to their accumulation
in other tissues. Almost all renal structures are susceptible to
accumulate AGEs, particularly CML under diabetic conditions
(Horie et al., 1997).
Aside from established direct toxicity, certain AGE, such
as CML-modified proteins, are powerful inducers of RAGE
signaling (Herold et al., 2007). One of the consequences of
AGE–RAGE interaction is the generation of ROS (Yan and
Harding, 1997; Jiang et al., 2004). AGE also perpetuate NF-
κB activation by de novo synthesis of NF-κB p65 (Bierhaus
et al., 2001), which promotes the expression of NF-κB-regulated
genes, including RAGE itself. Overexpression of RAGE enhances
the cell’s capacity to bind AGE, and initiates a vicious cycles
that perpetuates oxidative stress leading to tissue and organ
dysfunction in diabetes. In studies of diabetes-associated renal
diseases, the upregulation of RAGE has been linked to enhanced
levels of AGE (Jerums et al., 2003) and pronounced tissue injury,
which could be reduced by a functional RAGE blockade (Kuhla
et al., 2010). Our results show that treatment with either extract
interrupts the vicious cycle of CML-mediated RAGE/NF-κB
activation by decreasing protein glycation and CML formation
in both tissues, indicating that both examined extracts express
strong antiglycating activity in vivo. Reduction of CML levels,
particularly as observed in Cs extract-treated diabetic rats, could
be the outcome of improved hyperglycemia. On the other hand,
the prominent antiglycating activity of the Ld extract that was
observed in liver and kidney tissues of diabetic rats, in spite of
its weaker antihyperglycemic activity, could be the result of its
antioxidant effect and improved redox status.
The cell senses concentration changes of excess glucose
under hyperglycemic conditions via elevated levels of uridine
diphosphate-β-N-acetylglucosamine (UDP-GlcNAc), which is
the substrate for O-GlcNAc transferase (OGT) that catalyzes
the formation of a post-translational N-acetyl-glucosamine
modification of serine and threonine residues of nuclear
and cytoplasmic proteins. The increase in O-GlcNAc-modified
proteins in the liver and kidney of diabetic rats is probably
the result of increased activity of OGT (Kreppel and Hart,
1999; Konrad et al., 2001), while the significant decrease in
O-glycosylation in liver and kidney tissue of diabetic rats
after extract application could be the result of decreased
O-GlcNAcylation of OGT. Because glycosylation alters the
behavior of specific proteins by modulating their activities,
protein–protein interactions, DNA-binding activity, subcellular
localization and half-lives and proteolytic processing (Zachara
and Hart, 2004; Li et al., 2007), by limiting the level of
O-GlcNAcylation, the extracts play an important role in
maintaining normal cell signaling pathways under diabetic
conditions, with the MIX Ld/Cs providing the best inhibitory
effect on O-GlcNAcylation.
The presented data show that the administration of chestnut
and mushroom extracts, either individually or together, improved
the diabetes-induced pathological profile of liver and kidney
cells. Generally, treatment of diabetic rats with Cs extract
compared to the Ld extract provided better protection and
treatment with Mix Ld/Cs was equal or better that Cs. The
beneficial effect of the examined extracts was achieved not
only by reducing the glucose-triggered overproduction of free
radicals and enhancing the effectiveness of the cell’s antioxidant
defenses, but also through a marked antiglycation activity. Also,
the extracts significantly reduced non-enzymatic glycosylation in
diabetic rats in vivo, which leads to inhibition of CML-mediated
RAGE/NF-κB activation and enzymatic O-GlcNAcylation in
liver and kidney tissues. This should have positive impact on
various detrimental cellular processes, delaying the progression
of the diabetic complications. These findings may be relevant
with regard to the therapeutic potential of chestnut and
mushroom extracts in treating the diabetic condition and also
in the management of oxidative stress in other pathological
states.
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